leadf
logo-loader
viewPhosplatin Therapeutics

Phosplatin Therapeutics 'excited' about its prostate cancer data presentation next week

Phosplatin Therapeutics CEO Robert Fallon sat down with Proactive’s Christine Corrado at the BIO CEO & Investor Conference in New York. The New York-based, clinical stage oncology drug development company announced today it will present clinical data in metastatic castration resistant prostate cancer at the Genitourinary Cancers Symposium.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

PyroGenesis Canada to supply plasma torch for $1.8M with major iron ore producer

PyroGenesis Canada Inc (CVE:PYR) (OTCQB:PYRNF) (FRA:8PY) CEO Peter Pascali tells Proactive the group has signed an initial contract to provide a high-powered, one-megawatt plasma torch with accessories to a major iron ore producer for around $1.8 million. Pascali says the Montreal-based...

12 hours, 6 minutes ago

2 min read